Stock screener

REGN

Conviction 59HealthcareScan · Mon, Aug 10, 2026
REGN$808.65+3.10%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
Vol MA14 894.37K
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +0.00%· 1 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
REGENERON PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.regeneron.com
Price808.65
Change+3.10%
Gap-0.58%
Rel volume1.01×
Avg volume804.39K
Avg $ vol574.02M
SMA 20709.75
SMA 50660.45
SMA 200715.74
Price vs 50+22.44%
Price vs 200+12.98%
MA stackmixed
50/200 cross
Supertrendup · 729.36
RSI (14)83
MACD hist10.12
MACD crossbull · 9d
Stoch %K / %D100 / 97
ADX (14)41
+DI / −DI45 / 10
RSI divergenceBearish
MACD divergenceBearish
ATR %+2.58%
ADR %2.83%
52w high812.27
52w low545.94
From 52w high-0.45%
Above 52w low+48.12%
New 52w highYes
SqueezeOff
Bollinger width28.96%
%B0.98
Donchian pos99.74%
Donchian high809.09
Donchian low637.80
AVWAP (52w high)702.94
vs AVWAP high+15.04%
AVWAP (52w low)701.45
vs AVWAP low+15.28%
OBV trendUp
Chaikin MF (20)0.23
Today vs 20d1.01×
Avg vol (14d)894.37K
Avg vol (20d)804.39K
Avg $ vol (20d)574.02M
Market cap75.98B
RS 3m (vs SPY)+4.92%
RS 6m (vs SPY)-11.80%
RS line new highNo
Trend template7/8
Technical rank76.1
1 week+6.51%
1 month+21.69%
3 months+13.12%
6 months+2.95%
1 year+44.45%
YTD+4.17%
P/E16.87
P/B2.40
P/S5.30
P/FCF18.62
EPS41.48
Div yield0.49%
ROE14.21%
ROA10.80%
Debt/Eq0.11
Current3.34
EV/EBITDA18.68
Gross margin
Net margin31.41%
Rev growth0.99%
EPS growth2.09%
Price target828.95
Target upside2.51%
Analyst ratingBuy
Institutional101.75%
Ent. value77.01B
Revenue4.29B
Net income1.3B
Gross profit
Free cash flow4.08B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out103.02M
Employees15.41K
ListedTue, Apr 2, 1991
Free float98.32M
Float %94.6%
Short interest3.5M
Days to cover4.7d
Short volume56.5%
Squeeze score42 / 100
Next earnings
EPS forecast
Last EPS vs est$12.53 vs $8.00
Last surprise+56.6% beat
Setup gradeC
Conviction59 / 100
Pattern quality
Tech rank76.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance684.52
Support608.60
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in REGN · 10 recent

All disclosures →
MemberSideAmount
Alan Armstrong
Alan Armstrong
senate · R · OK · traded 2026-03-27
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2026-05-15
Sell$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-11-18
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-05-15
Buy$1K–$15K
Byron Donalds
Byron Donalds
house · R · FL · traded 2025-04-10
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-04-01
Sell$1K–$15K
Jefferson Shreve
Jefferson Shreve
house · R · IN · traded 2025-04-07
Sell$15K–$50K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-02-12
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in REGN · 10 sells

InsiderSideShares
RYAN ARTHUR F
Director · Common Stock · 2026-07-02
Sell200
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell7
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell24
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell6
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell4
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell5
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell15
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell1
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell14
RYAN ARTHUR F
Director · Common Stock · 2026-05-01
Sell2

SEC filings

EDGAR filings in REGN · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.